Death induced by doxorubicin (dox) in neuroblastoma (NB) cells was originally thought to occur via the Fas pathway, however since studies suggest that caspase-8 expression is silenced in most high stage NB tumors, it is more probable that dox-induced death occurs via a different mechanism. Caspase-8 silenced N-type invasive NB cell lines LAN-1 and IMR-32 were investigated for their sensitivity to dox, and compared to S-type noninvasive SH-EP NB cells expressing caspase-8. All cell lines had similar sensitivities to dox, independently of caspase-8 expression. Dox induced caspase-3, -7, -8 and -9 and Bid cleavage in S-type cells and death was blocked by caspase inhibitors but not by oxygen radical scavenger BHA. In contrast, dox-induced death in Ntype cells was caspase-independent and was inhibited by BHA. Dox induced a drop in mitochondrial membrane permeability in all cell lines. Dox-induced death in Stype cells gave rise to apoptotic nuclei, whereas in Ntype cells nuclei were non-apoptotic in morphology. Transfection of SH-EP cells with a dominant negative FADD mutant inhibited TRAIL-induced death, but had no effect on dox-induced apoptosis. These results suggest that S-type cells undergo apoptosis after dox treatment independently of death receptors, whereas N-type cells are killed by a caspase-independent mechanism.
Introduction
Neuroblastoma (NB) is a heterogeneous pediatric cancer derived from the sympathetic nervous system. Children over 1 year of age with stage IV NB tumors respond poorly to treatment, with a 5 year survival rate of only 30% (Spix et al., 2001) , whereas low stage tumors in infants frequently undergo spontaneous remission. Failure to undergo programmed cell death is a putative mechanism for cancer cell resistance to chemotherapy, while in contrast spontaneous remission is thought to be a result of increased apoptosis (Oue et al., 1996) . Apoptosis signaling occurs via two different pathways which converge on a common machinery of cell demise that is activated by caspases . The death receptor pathway is activated by ligands of the tumor necrosis factor (TNF) family which induce the trimerization of their cognate receptors (Daniel et al., 2001) . This aggregation triggers the recruitment of adaptor protein FADD, which in turn binds procaspase-8, inducing its activation by limited proteolytic cleavage. Effector caspases-3 and -7 are subsequently processed and activated, which ultimately results in DNA fragmentation and death. The mitochondrial pathway is activated by endogeneous stress such as DNA damage and is characterized by the loss of mitochondrial transmembrane potential and the release of cytochrome c from mitochondria (Green and Reed, 1998) . Cytosolic cytochrome c triggers the assembly of the apoptosome which recruits and activates caspase-9 and in turn caspases-3 and -7. Anti-apoptotic Bcl-2 family members such as Bcl-2 inhibit cytochrome c release by modulating the ability of Bax and Bak to facilitate opening of pores in the outer mitochondrial membrane (Wei et al., 2001) . Crosstalk between the two apoptosis signaling pathways occurs in some cells when caspase-8 converts an inactive form of Bid into a pro-apoptotic form that interacts with Bax and induces cytochrome c release (Scaffidi et al., 1999) .
Recent studies have shown that in addition to apoptosis, death receptor and mitochondrial signaling may activate alternative mechanisms of programmed cell death which are caspase-independent (Holler et al., 2000; Leist and Jaattela, 2001 ). These alternative mechanisms include necrosis and caspase-independent apoptosis which although are rare events in normal cells may be the prominent mode of death in tumor cells which have defects in the two apoptosis signaling pathways.
Several years ago, Fulda et al. (1997) reported that death in NB cells induced by chemotherapeutic drugs including doxorubicin (dox) was triggered via the Fas signaling pathway. However, conflicting evidence from other laboratories demonstrated that lymphocytes derived from Fas-deficient lpr mice were equally as sensitive to dox as those from wild type mice (Newton and Strasser, 2000) and transfection of cells with specific inhibitors of the Fas pathway such as cFLIP failed to block dox-induced death (Kataoka et al., 1998) . Recently, Fulda et al. (2001) attempted to provide an explanation for these discrepancies by demonstrating that the involvement of the Fas pathway in dox-induced apoptosis is cell type specific. In type I cells dox activates both the death receptor and mitochondrial pathways, whereas in type II cells only the mitochondrial pathway is activated, explaining why in some cells inhibitors of the death receptor pathway have no effect on dox-induced death.
If the death receptor pathway is important in doxinduced death in NB cells, i.e. they are type I cells, it follows that resistance to dox should be conferred by were incubated with dox for 48 h. Tetrazolium dye solution (Promega) was then added and the production of blue formazan product produced by viable cells measured at an absorbance of 570 nm . Percentage cell viability compared to untreated controls was calculated. Assays were performed at least three times and a representative experiment shown. (b) Cells were treated with 5 mg/ml dox for 24 or 48 h. Thirty mg of cellular NP-40 (1%) extracts were analysed by SDS -PAGE (12%) and Western blotting. Blots were incubated with anti-caspases-3 (Transduction Laboratories), -7 (PharMingen), -8 (MBL), -9 (New England Biolabs) or anti-Bid (R&D) antibodies followed by peroxidase-conjugated second antibodies (Nordic). Bound antibodies were detected using chemiluminescence. (c) Cells (10 5 cells/well in 96-well plates) were incubated with different concentrations of dox for 48 h alone or in the presence of 100 mM zVADfmk and cell viability assays were performed as above. (Teitz et al., 2000) . N-myc amplification is strongly linked to malignancy and chemoresistance in high stage tumors, and N-type cells are invasive in soft agar assays and form tumors when injected subcutaneously into nude mice (La Quaglia et al., 1996) . In contrast, similar to low stage NB tumors, the substrate adherent (S-type) cell lines such as SH-EP used by Fulda et al. (1998) are non-invasive, are not amplified for N-myc, and express caspase-8.
In the present study we investigated the mechanism of dox-induced death in N-type NB cell lines LAN-1 and IMR-32, which are silenced for caspase-8 expression, amplified for N-myc, and are completely resistant to TNF-related apoptosis inducing-ligand (TRAIL)-induced death (Hopkins-Donaldson et al., 2000) . We also assessed the role of the death receptor pathway in dox-induced death of the S-type NB cell line SH-EP used previously by Fulda et al. (1998) which are highly sensitive to TRAIL-induced death (Hopkins-Donaldson et al., 2000) . Cell viability tests were performed in order to compare the sensitivity to dox-induced death of N-type and S-type NB cell lines. No differences were observed between N-type and S-type cells in their sensitivity to dox after 48 h (Figure 1a ) or 72 h (data not shown). While the IC 50 for dox was 0.5 mg/ml in Jurkat T cells, the three NB cell lines were more resistant, with IC 50 values of between 1 and 5 mg/ml. Others have observed that dox concentrations as low as 0.5 mg/ml induced death in NB cell lines (Fulda et al., 1997) . This discrepancy with our findings might be due to different techniques used to measure cell death, or to variations in behavior of the same cell lines in different laboratories. In summary, whereas caspase-8 expression is crucial for death receptor-induced apoptosis in NB cells, sensitivity to dox is independent of caspase-8 expression. Dox-induced death in NB cells was investigated in more detail by measuring the extent of caspase and Bid cleavage by Western blotting (Figure 1b ). Cells were incubated with relatively high concentrations of dox (5 mg/ml) to ensure that any cleavage was detected. Cleavage of caspases-3, -7, -8 and -9 precursors was detected in SH-EP cells after 24 h dox treatment, and Bid cleavage occurred after 48 h. As expected, N-type cells were deficient for caspase-8 expression, and no caspases-3, -7 or Bid cleavage was observed after dox treatment. To further determine the importance of caspases in dox-induced death, NB cells were incubated with dox in the presence of the pan caspase inhibitor zVADfmk (Figure 1c) , or with specific inhibitors DEVD-FMK, IETD-FMK and LEHD-FMK which inhibit caspases-3 and -7, caspase-8 or caspases-9 activation respectively ( Figure  1d ). All caspase inhibitors blocked dox-induced death in S-type cells, whereas they had a much smaller effect on dox-induced death in N-type cells. Although cleavage of caspase-9 was detected in IMR-32 cells after 48 h treatment by Western blotting (Figure 1b) , the caspase-9 inhibitor LEHD-FMK had no effect on dox-induced death (Figure 1d ). Together these data suggest that whereas in S-type cells dox-induced death is caspase-dependent, caspases are not involved in the death of N-type cells.
Reactive oxygen species (ROS) are generated by mitochondria in conditions of stress and can result in the induction of either necrosis or apoptosis (Green and Reed, 1998) . Treatment of cells with dox in the presence of the oxygen scavenger 2(3)-t-butyl-4-hydroxyanisole (BHA) inhibited death in N-type cells but had no effect on S-type cell death (Figure 2a ). This suggests that ROS production is involved in the induction of caspase-independent N-type cell death induced by dox, whereas they are less important in the caspase-mediated death of S-type cells. Similarly, Vercammen et al. (1998) demonstrated that caspaseindependent necrosis induced by anti-Fas antibodies in the presence of zVADfmk was inhibited by BHA, whereas apoptosis induced by anti-Fas antibodies alone was not effected. Disruption of the mitochondrial membrane potential (DC m ) after 48 h dox treatment was observed in all three cell lines (Figure 2b ) with SH-EP having the greatest drop in DC m and IMR-32 the least. These results suggest that the mitochondria plays a role in the death of both S and N-type cells regardless of whether caspases are involved.
In order to determine the nature of death induced by dox in NB cell lines, the morphology of nuclei after dox treatment was investigated by 4,6-diamidino-2-phenylindole (DAPI) staining (Figure 3) . SH-EP nuclei contained condensed chromatin after 48 h incubation with 1 mg/ml dox with classic nuclear fragmentation that denotes apoptosis (Figure 3b ). In contrast, LAN-1 and IMR-32 cells treated with the same concentration of dox contained few apoptotic nuclei (Figure 3e,h) .
The majority of nuclei in these cells appeared intact, with no visible blebbing although chromatin was more condensed in comparison to untreated cells. Coincubation of cells with dox and zVADfmk resulted in a decrease in apoptotic SH-EP nuclei (Figure 3c ), but had no effect on the morphology of LAN-1 and IMR-32 cells (Figure 3f,i) . Therefore it would seem that N-type cells die by a predominantly caspaseindependent mechanism distinct from apoptosis.
Dox-induced death of SH-EP cells has been previously reported to occur via the death receptor pathway, as incubation of cells with F(ab') 2 anti-Fas antibody inhibited dox-induced death (Fulda et al., 1998) . We investigated this further by transfecting SH-EP cells with dominant negative FADD prior to dox treatment. SH-EP FADD-DN clones expressed large amounts of recombinant protein (Figure 4a ), and were completely resistant to TRAIL-induced death, suggesting that the death receptor pathway had been effectively blocked (Figure 4b ). In contrast, no increase in resistance to dox was observed in SH-EP FADD-DN cells, and dox-induced cleavage of caspases-3, -7, -8 and -9 could be detected (Figure 4b,c) . These results suggest that caspase-8 can be activated by chemotherapeutic drugs independently of death receptors, which has also been described for a non small cell lung cancer cell line and type II Jurkat T cells (Ferreira et al., 2000; Fulda et al., 2001) . It is possible that the mitochondrial pathway may be responsible for this activation as a result of an amplification loop whereby caspase-8 is activated by caspase-3, an observation that has been made in cell-free experiments (Slee et al., 1999) . If this is the case, it is likely that SH-EP cells are type II Figure 3 Morphology of NB nuclei after treatment with dox. SH-EP (a,b,c), IMR-32 (d,e,f) and LAN-1 (g,h,i) cells were incubated with medium (a,d,g), 1 mg/ml dox for 48 h alone (b,e,h) or in the presence of 100 mM zVADfmk (c,f,i). Cells (3610 5 cells/ml) were cytospun onto glass slides and fixed in acid acetic/ethanol (1 : 4), then stained for 20 min at 378C with 1 mg/ml DAPI in PBS. After washing, slides were mounted and examined under a fluorescent microscope 663 magnification rather than type I cells, as was originally suggested (Fulda et al., 1998) . Teitz et al. (2000) demonstrated that a NB cell line deleted for the caspase-8 gene underwent a 75% increase in dox induced apoptosis when transfected with caspase-8, which suggests that the presence of caspase-8 is crucial for dox-induced apoptosis in NB. Drug-induced caspase-independent death has been described previously in cancer cells deficient for caspases or Apaf-1 (Sartorius and Krammer, 2002; Miyazaki et al., 2001) . The mechanisms involved in this process are still unclear, but it is generally agreed that mitochondria are involved. Damage to mitochondria can result in the production of oxygen free radicals, and in a drop in mitochondrial transition permeability which coincides with the release of apoptosis-inducing factor (AIF). AIF relocates from the mitochondria to the nucleus and is responsible for caspase-independent large scale DNA fragmentation (Susin et al., 2000) . We found that the oxygen radical scavenger BHA blocks dox-induced death in N-type cells, and that dox induces a drop in mitochondrial membrane permeability, confirming a role for the mitochondria in doxinduced death. A role for NF-kB in dox induced death in N-type cells was recently suggested by Bian et al. (2001) who showed that transfection of N-type cells with the inhibitor Ik-BaM blocked dox-induced death. Further investigations into the roles of AIF and NFkB in dox-induced death in N-type cells are therefore warranted.
The tumor suppressor gene p53 is involved in the cellular response to cytotoxic agents, and exerts antiproliferative effects such as the induction of cell cycle arrest and apoptosis. Inactivation of p53 in cancer cells results in genomic instability and diminished apoptosis and has been proposed as a mechanism of drug resistance (McCurrach et al., 1997) . In contrast to many human cancers, p53 mutations are rare in neuroblastoma tumors and cell lines and while several studies have reported that p53 is functionally intact in neuroblastoma cells, (Goldman et al., 1996; McKenzie et al., 1999) , cytoplasmic sequestration and defective translocation of p53 protein have also been suggested as mechanisms of non-mutational inactivation (Ostermeyer et al., 1996) .
The cell lines used in this study have variable p53 statuses, from wild type (SH-EP, IMR-32) to loss of expression (LAN-1) (data not shown). p53 mutations do not seem to play a major role in the sensitivity to dox as all three cell lines were similarly killed by dox. However, it is currently not known whether the p53 expressed by IMR-32 cells is fully functional, and therefore the role of p53 in the inability of N-type cells to undergo caspase-dependent death in response to DNA damaging agents is not clear and is currently being investigated in further detail. The results of this study suggest that resistance of high stage NB tumors to chemotherapeutic drugs such as dox may be a result of an absence of caspase activation, and death via caspase-independent mechanisms is probably insufficient to prevent cancer spread. Combinations of dox with agents that induce apoptosis via the mitochondrial apoptosis signaling pathway may therefore be more successful than current treatments.
